Biopharmaceutical active pharmaceutical ingredients and finished-dose manufacturing
Nordmark Pharma manufactures biologically derived active ingredients and finished pharmaceuticals, with particular expertise in pancreatin and collagenase production. The company is mid-way through a SAP infrastructure overhaul—migrating master data, deploying S/4HANA Private Cloud, and adopting SAP Analytics Cloud—while simultaneously running process validation and quality documentation projects. This dual focus (system modernization + operational compliance) explains the hiring distribution: manufacturing and engineering roles dominate, but finance and operations staff are also being added to manage financial process stabilization and data governance during the transition.
Nordmark Pharma is a privately held pharmaceutical manufacturer based in Uetersen, Germany, employing 501–1,000 people. The company specializes in the development, manufacture, and licensing of biologically derived active pharmaceutical ingredients and finished medicinal products, serving global pharmaceutical and healthcare customers. Their core operations span raw-material sourcing, active ingredient production, finished-product manufacturing, and regulatory compliance across multiple geographic markets. Manufacturing, engineering, and quality functions form the operational backbone, supported by finance, logistics, and research teams.
Primary systems: SAP (S/4HANA, Finance & Controlling, Analytics Cloud), MES, LIMS, SQL Server, Oracle, with infrastructure on Citrix and VMware. Recently adopted SAP Analytics Cloud for reporting.
Active initiatives include S/4HANA Private Cloud development, master-data migration into SAP, process validation, database optimization, quality documentation, and lifecycle documentation maintenance.
Other companies in the same industry, closest in size